Related Experiment Video
Updated: Jul 18, 2026
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Research Progress of Traditional Chinese Medicine Monomer Inhibiting Metastatic Colonization of Ovarian Cancer Cells
Meng-Ya Wang1, Cheng-Xin Zhang1, Yu Wang1
1Heilongjiang University of Chinese Medicine, Harbin, China.
Abstract:
Ovarian cancer, a frequently occurring gynecological malignancy with a poor prognosis and a 5-year survival rate below 45%, often progresses due to metastatic colonization. This review highlights the potential of traditional Chinese medicine (TCM) monomers as anticancer agents that inhibit the metastatic colonization of ovarian cancer cells. TCM monomers exhibit various mechanisms of action, including (1) inhibiting epithelial-to-mesenchymal transformation by modulating cell adhesion molecules; (2) reducing extracellular matrix damage through inhibition of degrading enzymes; (3) affecting cytoskeletal dynamics to alter cell movement; and (4) preventing angiogenesis by downregulating angiogenic factors. Additionally, TCM monomers can reshape the tumor microenvironment, enhance immune responses, and induce oxidative stress, resulting in reduced proliferation and survival of cancer cells. The comprehensive action of TCM monomers makes them promising candidates for individualized, multi-target therapies in drug-resistant cases. This paper reviews the current research on the mechanisms through which TCM monomers combat metastatic colonization, aiming to provide insights for future studies and clinical applications in ovarian cancer treatment, ultimately offering hope to affected patients.
Insights
Traditional Chinese Medicine (TCM) monomers show promise in inhibiting ovarian cancer metastasis. These natural compounds offer multi-target approaches for drug-resistant ovarian cancer, improving patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Integrative Medicine
Background:
- Ovarian cancer has a poor prognosis, with metastasis being a primary cause of mortality.
- Limited effective treatments exist for advanced and drug-resistant ovarian cancer.
- Traditional Chinese Medicine (TCM) offers a rich source of compounds with potential anticancer properties.
Purpose of the Study:
- To review the mechanisms by which TCM monomers inhibit ovarian cancer metastatic colonization.
- To explore the potential of TCM monomers as novel therapeutic agents for ovarian cancer.
- To provide insights for future research and clinical applications of TCM in ovarian cancer treatment.
Main Methods:
- Literature review of preclinical and clinical studies on TCM monomers and ovarian cancer metastasis.
- Analysis of the molecular mechanisms targeted by TCM monomers, including cell adhesion, extracellular matrix degradation, cytoskeletal dynamics, and angiogenesis.
- Evaluation of TCM monomers' effects on the tumor microenvironment and immune response.
Main Results:
- TCM monomers inhibit epithelial-to-mesenchymal transition by modulating cell adhesion molecules.
- TCM monomers reduce extracellular matrix damage by inhibiting degrading enzymes.
- TCM monomers affect cytoskeletal dynamics, angiogenesis, tumor microenvironment, and immune responses, leading to reduced cancer cell proliferation and survival.
Conclusions:
- TCM monomers possess multifaceted mechanisms to combat ovarian cancer metastasis.
- These compounds represent promising candidates for individualized, multi-target therapies, especially in drug-resistant cases.
- Further research and clinical validation are warranted to integrate TCM monomers into ovarian cancer treatment strategies.
More Related Videos
08:17Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
05:42Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
Related Concept Videos
01:56Gastrulation
01:19Cell Migration